Gowling WLG advised Nanexa on the deal. The transaction involved a material transfer and feasibility study agreement with global pharmaceutical company Novo Nordisk A/S. The deal facilitates...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here